Charles River Laboratories Stock Price

1.78 (0.55%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Charles River Laboratories International Inc CRL NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
1.78 0.55% 324.15 11:18:22
Open Price Low Price High Price Close Price Prev Close
321.55 318.59 324.35 322.37
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,569 43,985 $ 322.22 $ 14,172,743 309,142 133.57 - 327.72
Last Trade Time Type Quantity Stock Price Currency
11:18:43 3 $ 324.345 USD

Charles River Laboratories Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 16.13B 49.74M 43.62M $ 2.62B $ 271.82M 5.06 46.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Charles River Laboratories News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CRL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week309.96327.72306.91320.78312,49714.194.58%
1 Month279.83327.72273.52301.43325,33244.3215.84%
3 Months260.26327.72249.48288.21319,53363.8924.55%
6 Months234.90327.72219.79266.43311,62189.2537.99%
1 Year135.30327.72133.57227.00332,987188.85139.58%
3 Years105.86327.7295.58163.72338,880218.29206.21%
5 Years80.41327.7267.20134.51341,950243.74303.12%

Charles River Laboratories Description

Charles River Laboratories is a leading provider of drug discovery and development services. With roughly 50% of market share worldwide, the research model and services segment is the leading provider of animal models for laboratory testing. About half of the company's revenue comes from drug discovery and preclinical testing, and one fourth comes from the manufacturing support segment.

Your Recent History
Charles Ri..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.